TCAP-1, a bioactive peptide derived from the ancient teneurin protein family, reduced anxiety and blocked cocaine-seeking behavior in rodents while promoting brain cell growth, suggesting a new peptide-based approach to mood disorders.
New peptide targetTCAP-1 reduced anxiety in three standard rodent tests and blocked CRF-mediated cocaine-seeking, while also promoting neuronal growth — combining structural and behavioral effects in a single peptide
What the researchers found
The review synthesizes evidence on the teneurin/TCAP-latrophilin system with several key findings:
• TCAP peptides (1-4) are bioactive sequences embedded within teneurin proteins that are structurally similar to corticotropin-releasing factor (CRF), a peptide central to stress and mood disorders
• Synthetic TCAP-1 induces long-term changes in neuronal structure in hippocampal cultures: increased neurite outgrowth, dendritic branching, and axon growth via an association with dystroglycans
• In rodent behavioral models, TCAP-1 reduced anxiety responses in the elevated plus-maze, open-field test, and acoustic startle test
• TCAP-1 inhibited CRF-mediated cocaine-seeking behavior
• Teneurins interact with latrophilins (adhesion GPCRs) forming transsynaptic adhesion pairs, providing a structural and signaling basis for mood regulation
Why it matters
Current treatments for mood disorders primarily target serotonin, norepinephrine, and dopamine systems, but many patients don't respond adequately. The discovery of the teneurin/TCAP system introduces an entirely new peptide signaling axis that regulates both brain structure and anxiety-related behavior. Because TCAP resembles CRF — a well-validated stress target — but appears to have opposite effects (anxiolytic rather than anxiogenic), it could represent a new class of anti-anxiety peptide therapeutics.
How the study worked
Narrative review synthesizing findings from molecular biology (teneurin-latrophilin interaction characterization), in vitro neuronal culture experiments (embryonic and primary hippocampal cultures treated with synthetic TCAP-1), and behavioral pharmacology studies (rodent anxiety and addiction models).
What this study cannot tell us
This is a narrative review of primarily preclinical data. All behavioral findings are from rodent models. No human data or clinical trials are described. The structural similarity between TCAP and CRF does not guarantee similar pharmacological utility. The mechanism by which TCAP-1 reduces anxiety while resembling an anxiogenic peptide family is not fully explained. Long-term safety of TCAP administration has not been evaluated.
How to read the evidence
This is a narrative review of preclinical evidence including in vitro cell culture and rodent behavioral studies. While the findings are consistent and biologically plausible, no human data exist. The evidence represents early-stage target discovery rather than therapeutic validation.
When this study was published
Published in 2016, this review captures the teneurin/TCAP field at an early but exciting stage. Research on this system has continued, though no clinical applications have emerged yet.
The bigger picture
The teneurin/TCAP-latrophilin system is one of the most evolutionarily ancient signaling pathways in neuroscience, predating the vertebrate nervous system. The finding that these peptides modulate both neural structure and mood-related behavior connects developmental neurobiology with psychiatric disease in a new way. If TCAP-based therapeutics can be developed, they would represent the first drugs targeting this ancient signaling system.
Questions still open
- Can TCAP-1 or analogs be developed into clinically viable anxiolytic drugs that work through the teneurin-latrophilin pathway?
- Why does TCAP-1 have anxiolytic effects despite structural similarity to the anxiogenic CRF peptide family?
- Could the TCAP-latrophilin system be a target for treating both anxiety disorders and CRF-mediated addiction simultaneously?
Common questions
What are TCAP peptides?
Could TCAP peptides become a new treatment for anxiety?
Read the original research
Teneurins, TCAP, and latrophilins: roles in the etiology of mood disorders.
Translational neuroscience, 7(1), 17-23
Citation
Woelfle, Rebecca; D'Aquila, Andrea L; Lovejoy, David A. (2016). Teneurins, TCAP, and latrophilins: roles in the etiology of mood disorders.. Translational neuroscience, 7(1), 17-23. https://doi.org/10.1515/tnsci-2016-0004